Speaker illustration

Doctor Katsuomi Iwakura

Sakurabashi-Watanabe Hospital, Osaka (Japan)

Member of:

European Society of Cardiology

Dr. Iwakura received M.D. in 1984, and Ph.D. in 1989 from Osaka University Graduate School of Medicine. He is specialized in echocardiography, and also interested in heart failure and in ischemic heart disease. He has been a cardiologist in Sakurabashi Watanabe Hospital, Osaka, Japan, since 1993, and is now a vice-president of Sakurabashi Watanabe Hospital.

Triglyceride glucose index, a novel marker of insulin resistance, predicts outcomes in patients with heart failure with preserved ejection fraction.

Event: ESC Congress 2023

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Further insights into inflammation, immunology, and insulin resistance in heart failure

Thumbnail

Development of the new risk score to predict occurrence of atrial fibrillation early after acute myocardial infarction.

Event: ESC Congress 2022

Topic: Atrial Stressors

Session: Atrial fibrillation in context of concomitant medical conditions

Thumbnail

Prediction of functional capacity by the HFA-PEFF score in patients with acute decompensated heart failure with preserved ejection fraction: a post-hoc analysis from the PURSUIT-HFpEF registry.

Event: ESC Congress 2021 - The Digital Experience

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Chronic heart failure e-posters

Thumbnail

Validation of the HFA-PEFF- and H2FPEF score in Japanese patients with heart failure with preserved ejection fraction.

Event: ESC Congress 2020

Topic: Diagnostic Methods

Session: Circulating and Imaging Biomarkers in Heart Failure

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb